Mental health status and related influencing factors of COVID‐19 survivors in Wuhan, China
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:10 |
---|---|
Enthalten in: |
Clinical and Translational Medicine - 10(2020), 2, Seite n/a-n/a |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Chaomin Wu [VerfasserIn] |
---|
Links: |
doi.org [kostenfrei] |
---|
Themen: |
---|
doi: |
10.1002/ctm2.52 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
DOAJ035055820 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | DOAJ035055820 | ||
003 | DE-627 | ||
005 | 20230502065641.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230227s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1002/ctm2.52 |2 doi | |
035 | |a (DE-627)DOAJ035055820 | ||
035 | |a (DE-599)DOAJb2e601d9425040f6bb335257a2300c63 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
050 | 0 | |a R5-920 | |
100 | 0 | |a Chaomin Wu |e verfasserin |4 aut | |
245 | 1 | 0 | |a Mental health status and related influencing factors of COVID‐19 survivors in Wuhan, China |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
650 | 4 | |a COVID‐19 | |
650 | 4 | |a follow‐up | |
650 | 4 | |a mental health | |
650 | 4 | |a survivors | |
653 | 0 | |a Medicine (General) | |
700 | 0 | |a Xianglin Hu |e verfasserin |4 aut | |
700 | 0 | |a Jianxin Song |e verfasserin |4 aut | |
700 | 0 | |a Dong Yang |e verfasserin |4 aut | |
700 | 0 | |a Jie Xu |e verfasserin |4 aut | |
700 | 0 | |a Kebin Cheng |e verfasserin |4 aut | |
700 | 0 | |a Dechang Chen |e verfasserin |4 aut | |
700 | 0 | |a Ming Zhong |e verfasserin |4 aut | |
700 | 0 | |a Jinjun Jiang |e verfasserin |4 aut | |
700 | 0 | |a Weining Xiong |e verfasserin |4 aut | |
700 | 0 | |a Ke Lang |e verfasserin |4 aut | |
700 | 0 | |a Yan Tao |e verfasserin |4 aut | |
700 | 0 | |a Xiaoqin Lin |e verfasserin |4 aut | |
700 | 0 | |a Guohua Shi |e verfasserin |4 aut | |
700 | 0 | |a Liwen Lu |e verfasserin |4 aut | |
700 | 0 | |a Longci Pan |e verfasserin |4 aut | |
700 | 0 | |a Lei Xu |e verfasserin |4 aut | |
700 | 0 | |a Xin Zhou |e verfasserin |4 aut | |
700 | 0 | |a Yuanlin Song |e verfasserin |4 aut | |
700 | 0 | |a Ming Wei |e verfasserin |4 aut | |
700 | 0 | |a Junhua Zheng |e verfasserin |4 aut | |
700 | 0 | |a Chunling Du |e verfasserin |4 aut | |
773 | 0 | 8 | |i In |t Clinical and Translational Medicine |d Wiley, 2013 |g 10(2020), 2, Seite n/a-n/a |w (DE-627)DOAJ000049395 |x 20011326 |7 nnns |
773 | 1 | 8 | |g volume:10 |g year:2020 |g number:2 |g pages:n/a-n/a |
856 | 4 | 0 | |u https://doi.org/10.1002/ctm2.52 |z kostenfrei |
856 | 4 | 0 | |u https://doaj.org/article/b2e601d9425040f6bb335257a2300c63 |z kostenfrei |
856 | 4 | 0 | |u https://doi.org/10.1002/ctm2.52 |z kostenfrei |
856 | 4 | 2 | |u https://doaj.org/toc/2001-1326 |y Journal toc |z kostenfrei |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_DOAJ | ||
912 | |a SSG-OLC-PHA | ||
951 | |a AR | ||
952 | |d 10 |j 2020 |e 2 |h n/a-n/a |